Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.
Illumina is a biotechnology company founded in 1998 located in San Diego, California, developing and selling instruments, reagents, and services for DNA sequencing applications.
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases
A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies
A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
A pharmaceutical company developing treatments for cancer and chronic diseases. It was founded in 2006 and is located in San Diego, California.
BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases.
Senti Biosciences is a synthetic biology company.
Recursion Pharmaceuticals is a biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated.
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
A company developing small molecule therapies to treat cancer
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
A company that develops and commercializes products for the treatment of dermatological diseases
A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases
A biopharmaceutical company focused on the research and development of antibiotics to treat serious infections
A company developing treatments for dermatology and immunology.
A biotechnology company researching and developing therapies to increase human lifespan.
A biotechnology company developing therapies to cure rare diseases
Medicago is a biopharmaceutical company founded in 1999, based in Quebec, Quebec, Canada, that uses plant-based manufacturing to develop vaccines and protein-based therapeutics. In 2013 became a subsidiary of Mitsubishi Tanabe Pharma Corporation.
A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions